Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport double versus multiple gastrocnemius injections in children with cerebral palsy
2005-005197-78Phase 4
- Sponsor
- Nottingham University Hospitals
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of botulinum toxin type A in cerebral palsy (CP) and Muscle spasm (2 arms), sponsored by Nottingham University Hospitals. Primary endpoint: Change in gait at 4 weeks after each treatment.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)Muscle spasm
Beyond the preview
Go deeper on 2005-005197-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005197-78.